Company page
Newron Pharmaceuticals S.p.a.
Newron Pharmaceuticals S.p.A. is a public company listed on the Swiss market under the ticker NWRN. The company has a market capitalization of approximately CHF 315.95 million. Newron focuses on developing innovative treatments for patients with neurological diseases.
- Ticker
- NWRN:SIX
- Asset type
- Stock
- Market cap
- $316.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SIX
- Currency
- CHF